| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/06/2002 | WO2002043733A1 Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease |
| 06/06/2002 | WO2002043732A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/06/2002 | WO2002043731A2 Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
| 06/06/2002 | WO2002043730A1 Use of mdr-1 inducers for treating or preventing diseases |
| 06/06/2002 | WO2002043729A1 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylylacetic acid |
| 06/06/2002 | WO2002043728A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | WO2002043727A1 Treatment of psychiatric disorders with trimethyl-bicyclo[2.2.1]heptane derivatives |
| 06/06/2002 | WO2002043726A1 Method for inducing cognition enhancement by use of trimethyl-bicyclo[2.2.1]heptane derivatives |
| 06/06/2002 | WO2002043725A1 Treatment of obsessive compulsive disorder |
| 06/06/2002 | WO2002043724A1 Combination therapy for treatment of serotonergic disorders |
| 06/06/2002 | WO2002043723A1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt |
| 06/06/2002 | WO2002043722A2 Copper chelators for treating ocular inflammation |
| 06/06/2002 | WO2002043721A1 Treatment of statin side effects |
| 06/06/2002 | WO2002043720A2 Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer |
| 06/06/2002 | WO2002043719A2 Composition and method for treating snoring |
| 06/06/2002 | WO2002043718A2 Chemotherapeutic agents for the treatment of angiogenic diseases |
| 06/06/2002 | WO2002043717A2 Treatment of varicose veins |
| 06/06/2002 | WO2002043716A2 Method for regulating prostate gland volume with insulin sensitizers |
| 06/06/2002 | WO2002043715A2 Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence |
| 06/06/2002 | WO2002043714A2 Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence |
| 06/06/2002 | WO2002043713A2 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence |
| 06/06/2002 | WO2002043712A2 Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence |
| 06/06/2002 | WO2002043709A1 Method for producing preparation containing bioactive substance |
| 06/06/2002 | WO2002043707A1 Pharmaceutical formulation |
| 06/06/2002 | WO2002043704A1 Composition improved in solubility or oral absorbability |
| 06/06/2002 | WO2002043703A1 Powdery preparations and proecss for producing the same |
| 06/06/2002 | WO2002043702A2 Pharmaceutical compositions for inhalation |
| 06/06/2002 | WO2002043701A2 Method of making particles for use in a pharmaceutical composition |
| 06/06/2002 | WO2002043691A1 Skin cream stimulating the surface bloodstream |
| 06/06/2002 | WO2002043689A2 Cosmetic, pharmaceutical and dermatological products |
| 06/06/2002 | WO2002043685A2 Cosmetic and/or pharmaceutical emulsions |
| 06/06/2002 | WO2002043668A2 Antimycobacterial compounds and method for making the same |
| 06/06/2002 | WO2002043666A2 Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function |
| 06/06/2002 | WO2002043664A2 Reducing cellular damage in the human body |
| 06/06/2002 | WO2002043663A2 Tetrapartate prodrugs |
| 06/06/2002 | WO2002043662A2 Dietary composition containing conjugated linoleic acid and calcium for improved health |
| 06/06/2002 | WO2002043659A2 Composition containing statins and calcium for improved cardiovascular health |
| 06/06/2002 | WO2002043655A2 Inhibition of exoprotein production from grampositive bacteria |
| 06/06/2002 | WO2002043654A2 Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions |
| 06/06/2002 | WO2002043653A2 Crystalline glucosamine sulphate metal salts |
| 06/06/2002 | WO2002043652A2 Anti-proliferative drugs |
| 06/06/2002 | WO2002043648A2 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | WO2002043618A1 Methods for contemporaneous administration of levamisole and 5-fluorouracil |
| 06/06/2002 | WO2002043580A2 Production of microspheres |
| 06/06/2002 | WO2002043566A2 Devices and methods for treating low blood sugar levels |
| 06/06/2002 | WO2002043507A2 Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| 06/06/2002 | WO2002028364A3 Stabilization of solid thyroid drug formulations |
| 06/06/2002 | WO2002026240A3 Inhibition of antigen presentation with poorly catabolized polymers |
| 06/06/2002 | WO2002024665A8 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 06/06/2002 | WO2002024223A3 Prevention and treatment of streptococcal and staphylococcal infection |
| 06/06/2002 | WO2002024148A3 Method or treatment of tumors using transforming growth factor-alpha |
| 06/06/2002 | WO2002024144A3 Use of transcription factors for treating inflammation and other diseases |
| 06/06/2002 | WO2002024001A3 Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use |
| 06/06/2002 | WO2002021933A3 Feedstuff or a feedstuff additive used as a performance promoter or as an appetite promoter for domestic animals |
| 06/06/2002 | WO2002020726A3 Method for increasing the effectiveness of antiinfective agents |
| 06/06/2002 | WO2002020489A3 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 06/06/2002 | WO2002020483A8 Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 06/06/2002 | WO2002020474A3 Resorcinol derivatives |
| 06/06/2002 | WO2002018320A3 INHIBITORS OF α4 MEDIATED CELL ADHESION |
| 06/06/2002 | WO2002017900A9 Modulators of us28 (chemokines) for treating cytomegalovirus infections |
| 06/06/2002 | WO2002015866A3 USE OF CYCLIC 2,4-DIPHOSPHOGLYCERATES (cDGP) AND/OR DERIVATIVES THEREOF IN COSMETIC AND DERMATOLOGICAL FORMULATIONS |
| 06/06/2002 | WO2002015809A3 Dental composition for hypersensitive teeth |
| 06/06/2002 | WO2002015721A3 Foodstuff and animal feedstuff supplement compositions |
| 06/06/2002 | WO2002014343A8 Bufadienolide derivatives and use as immunosuppressive, antiinflammatory and analgesic agents |
| 06/06/2002 | WO2002014314A3 Substituted pyrazoles |
| 06/06/2002 | WO2002013804A3 Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid |
| 06/06/2002 | WO2002012242A3 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/06/2002 | WO2002012198A3 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 06/06/2002 | WO2002011676A3 Method of using diketopiperazines and composition containing them |
| 06/06/2002 | WO2002011551A3 Oil/fat composition |
| 06/06/2002 | WO2002007716A3 Method for treating angina |
| 06/06/2002 | WO2002007704A3 Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone |
| 06/06/2002 | WO2002007683B1 Antimicotic nail varnish composition |
| 06/06/2002 | WO2002006299A3 Therapeutic uses for aminosterol compounds |
| 06/06/2002 | WO2002004406A3 9-substituted minocycline compounds |
| 06/06/2002 | WO2002003920A3 Method for treatment of reactive arthritis or bursitis |
| 06/06/2002 | WO2002003914A3 Improved thyroid hormone formulations |
| 06/06/2002 | WO2002002606A3 Immunisation against chlamydia pneumoniae |
| 06/06/2002 | WO2001097791A3 Use of c4-c10 acids for preventing gram-negative bacterial infections |
| 06/06/2002 | WO2001094333A3 Process for the preparation of benzoyl substituted bicyclic compounds and chiral benzopyran derivatives |
| 06/06/2002 | WO2001094293A3 Benzamide ligands for the thyroid receptor |
| 06/06/2002 | WO2001093841A3 Barbituric acid analogs as therapeutic agents |
| 06/06/2002 | WO2001091696A3 Use of biguanide derivatives for making a medicine having a wound healing effect |
| 06/06/2002 | WO2001090360A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/06/2002 | WO2001090129A3 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds |
| 06/06/2002 | WO2001090068A3 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases |
| 06/06/2002 | WO2001088116A9 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 06/06/2002 | WO2001087849A3 Modulators of tnf- alpha signaling |
| 06/06/2002 | WO2001087282A3 Pepsin inhibition by alginates |
| 06/06/2002 | WO2001085681A3 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
| 06/06/2002 | WO2001082917A3 Treatment of hypertriglyceridemia and other conditions using lxr modulators |
| 06/06/2002 | WO2001080860A3 Daily treatment for erectile dysfunction using a pde5 inhibitor |
| 06/06/2002 | WO2001080840A3 Cytotoxic agents comprising single-stranded and/or looped dna |
| 06/06/2002 | WO2001074768A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 06/06/2002 | WO2001072287B1 Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression |
| 06/06/2002 | WO2001068643A3 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 06/06/2002 | WO2001068614A3 5-substituted arylpyrimidines |
| 06/06/2002 | WO2001068098A3 Cephalotaxine alkaloid combination compositions and uses thereof |
| 06/06/2002 | WO2001068072A3 Composition for use in treatment of ocular hypertension and glaucoma |
| 06/06/2002 | WO2001068071A3 Use of natural chrysanthone compounds having antiangiogenic activity |